Just days after an upbeat R&D event, Neurocrine Biosciences has found itself having to report a phase 3 failure. | Neurocrine’s Ingrezza, approved to treat certain uncontrolled movements, failed to ...

When picturing signs of dementia to look for, the first ones that come to mind may be memory loss, struggling to think of the right word and having difficulty problem-solving. You may have also heard ...

People with autism spectrum disorder (ASD) and intellectual disability (ID) often experience involuntary movements, which disrupt their ability to perform many tasks. A new device could help reduce ...

Tardive dyskinesia (TD) is an involuntary neurological movement disorder that is usually a side effect of certain dopamine receptor blocking drugs. It mainly affects the face but can also cause ...

Adrian is the first paediatric patient with GNAO1 in Asia to undergo Deep Brain Stimulation surgery for this condition. SINGAPORE – Fewer than 500 people worldwide are known to have a rare genetic ...

Tardive dyskinesia shares features with other movement disorders, such as Tourette syndrome and drug-induced Parkinsonism. But a diagnostic evaluation can reveal which condition is causing the ...

Athetosis and chorea are two types of involuntary movements that can occur in children and adults with neurological conditions, such as cerebral palsy. The movements have different features, and the ...

The case description for a Case Records of the Massachusetts General Hospital appears below. What is the diagnosis? Cast your vote. The correct diagnosis, along with the full description of the case ...

Neurocrine Biosciences said on Monday its drug failed to meet the main goal in a late-stage clinical trial in patients with a type of disorder that disrupts the brain's ability to control muscles.

Kristin Weiland is a documentary film producer and writer with a background in crisis management and ethnographic research. She specializes in investigative and social impact documentary projects, and ...